Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationEMA Consultation Concept Paper on the revision of Annex 11 of the guidelines on Good Manufacturing Practice for medicinal products – Computerised Systems.
EMA Consultation Draft guideline on the development and data requirements of potency tests for veterinary cell-based therapy products and the relation to clinical efficacy.
EMA Consultation The European Medicines Agency has published for public consultation a reflection paper on criteria to be considered for the evaluation of new active substance (NAS) status of biological substances.
The ICH E19 Introductory Training Presentation is now available on the ICH website
Several companies have contacted the MHRA regarding cannabis-based products for medicinal use. This blog provides information on what authorisations are required in order to MHRA Manufacturing Licence Application manufacture within this sector of the pharmaceutical industry.
This is the first report to capture the implications of COVID-19 for vaccine markets.
MHRA Notice Access Consortium Good Manufacturing Practice (GMP) Statement Published 15 November 2022
EMA - Human Medicines Highlights Newsletter, Issue 163 (Nov 22) released.
ICH M11 guideline (Step 2b), ICH M11 technical specification (Step 2b) and ICH M11 template (Step 2b) - open for consultation.
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2022